Harms Colonoscopy complications ‐ bowel perforation
It is very uncertain whether intensive follow‐up changes harms Colonoscopy complications ‐ bowel perforation compared with less intensive follow‐up (very low certainty).
1 finding from 1 review
Outcomes* · people with primary open‐angle glaucoma and no previous glaucoma surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Control of intraocular pressure · people with primary open‐angle glaucoma and no previous glaucoma surgery
Low‐ showed no clear difference in control of intraocular pressure compared with high‐energy diode trans‐scleral cyclophotocoagulation (low certainty).
1 finding from 1 review
Mean change in intraocular pressure · people with primary open‐angle glaucoma and no previous glaucoma surgery
1 finding from 1 review
Decrease in visual acuity · people with primary open‐angle glaucoma and no previous glaucoma surgery
Low‐ showed no clear difference in decrease in visual acuity compared with high‐energy diode trans‐scleral cyclophotocoagulation (low certainty).
1 finding from 1 review
Mean visual field · people with primary open‐angle glaucoma and no previous glaucoma surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mean number of antiglaucoma medications at 1‐year · people with primary open‐angle glaucoma and no previous glaucoma surgery
1 finding from 1 review
Proportion needing additional glaucoma surgery at 1‐year · people with primary open‐angle glaucoma and no previous glaucoma surgery
Low‐ showed no clear difference in additional glaucoma surgery compared with high‐energy diode trans‐scleral cyclophotocoagulation (low certainty).
1 finding from 1 review
Adverse events: atonic pupil · people with primary open‐angle glaucoma and no previous glaucoma surgery
Low‐ showed no clear difference in adverse events: atonic pupil compared with high‐energy diode trans‐scleral cyclophotocoagulation (low certainty).
1 finding from 1 review
Weight loss of at least 5% at ≥ 12 months ‐ not measured · overweight and obese participants without T2DM (weight‐reducing phase followed by weight maintenance phase)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cardiovascular mortality ‐ not measured · overweight and obese participants without T2DM (weight‐reducing phase followed by weight maintenance phase)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in DBP (mmHg) at ≥ 12 months · overweight and obese participants without T2DM (weight‐reducing phase followed by weight maintenance phase)
1 finding from 1 review
LDL cholesterol (mmol/L), change from baseline · overweight and obese participants without T2DM (weight‐reducing phase followed by weight maintenance phase)
1 finding from 1 review
Constipation at 3 to < 12 months ‐ not measured · overweight and obese participants without T2DM (weight‐reducing phase followed by weight maintenance phase)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in weight (kg) · overweight and obese participants with T2DM (weight‐reducing phase followed by weight‐maintenance phase)
2 findings from 1 review
Weight loss of at least 5% at ≥ 12 months ‐ not measured · overweight and obese participants with T2DM (weight‐reducing phase followed by weight‐maintenance phase)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cardiovascular mortality ‐ not measured · overweight and obese participants with T2DM (weight‐reducing phase followed by weight‐maintenance phase)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in DBP (mmHg) at ≥ 12 months · overweight and obese participants with T2DM (weight‐reducing phase followed by weight‐maintenance phase)
1 finding from 1 review
HbA1c (glycated haemoglobin), change · overweight and obese participants with T2DM (weight‐reducing phase followed by weight‐maintenance phase)
1 finding from 1 review
LDL cholesterol (mmol/L), change from baseline · overweight and obese participants with T2DM (weight‐reducing phase followed by weight‐maintenance phase)
1 finding from 1 review